Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.22514480 |
2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.22514480 |
3 | modulation by symbiont of host immune response (GO:0052553) | 6.22514480 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.22514480 |
5 | modulation by symbiont of host defense response (GO:0052031) | 6.22514480 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.22514480 |
7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.44268676 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.28136348 |
9 | neutrophil activation involved in immune response (GO:0002283) | 5.00879944 |
10 | macrophage activation involved in immune response (GO:0002281) | 4.86318767 |
11 | immunoglobulin mediated immune response (GO:0016064) | 4.82396912 |
12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.79447463 |
13 | * positive regulation of interferon-alpha production (GO:0032727) | 4.60759548 |
14 | positive regulation of antigen processing and presentation (GO:0002579) | 4.59727856 |
15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.52039954 |
16 | microglial cell activation (GO:0001774) | 4.51793159 |
17 | respiratory burst (GO:0045730) | 4.48021659 |
18 | * regulation of interferon-alpha production (GO:0032647) | 4.38840000 |
19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.17439265 |
20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17439265 |
21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.16014225 |
22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.15867536 |
23 | detection of other organism (GO:0098543) | 4.08465952 |
24 | response to host immune response (GO:0052572) | 4.07953488 |
25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.07953488 |
26 | detection of bacterium (GO:0016045) | 4.02570738 |
27 | * response to peptidoglycan (GO:0032494) | 4.01039724 |
28 | regulation of antigen processing and presentation (GO:0002577) | 3.89757030 |
29 | granulocyte activation (GO:0036230) | 3.87559637 |
30 | neutrophil activation (GO:0042119) | 3.87452122 |
31 | positive regulation of B cell differentiation (GO:0045579) | 3.80637446 |
32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.74684666 |
33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.72863999 |
34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.72668294 |
35 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.68950600 |
36 | response to host (GO:0075136) | 3.68950600 |
37 | response to host defenses (GO:0052200) | 3.68950600 |
38 | macrophage activation (GO:0042116) | 3.64991078 |
39 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.62504916 |
40 | myeloid cell activation involved in immune response (GO:0002275) | 3.57793847 |
41 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.56599425 |
42 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.54138058 |
43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.53202323 |
44 | B cell mediated immunity (GO:0019724) | 3.52056094 |
45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.49572373 |
46 | cellular extravasation (GO:0045123) | 3.49129872 |
47 | defense response to protozoan (GO:0042832) | 3.48501838 |
48 | B cell receptor signaling pathway (GO:0050853) | 3.48475553 |
49 | * type I interferon signaling pathway (GO:0060337) | 3.47688838 |
50 | * cellular response to type I interferon (GO:0071357) | 3.47688838 |
51 | * response to type I interferon (GO:0034340) | 3.45326780 |
52 | myeloid dendritic cell differentiation (GO:0043011) | 3.44878922 |
53 | regulation of B cell differentiation (GO:0045577) | 3.44473390 |
54 | detection of external biotic stimulus (GO:0098581) | 3.44252204 |
55 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.41877114 |
56 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.40923105 |
57 | cellular response to exogenous dsRNA (GO:0071360) | 3.39143281 |
58 | NIK/NF-kappaB signaling (GO:0038061) | 3.38423160 |
59 | myeloid dendritic cell activation (GO:0001773) | 3.35669706 |
60 | natural killer cell mediated immunity (GO:0002228) | 3.31923117 |
61 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.31923117 |
62 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28748272 |
63 | * positive regulation of interferon-beta production (GO:0032728) | 3.28333642 |
64 | I-kappaB phosphorylation (GO:0007252) | 3.28141664 |
65 | germinal center formation (GO:0002467) | 3.27504846 |
66 | * response to muramyl dipeptide (GO:0032495) | 3.26526607 |
67 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.26204064 |
68 | detection of molecule of bacterial origin (GO:0032490) | 3.23427089 |
69 | cellular response to interferon-beta (GO:0035458) | 3.22289803 |
70 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.19505803 |
71 | cellular response to zinc ion (GO:0071294) | 3.15965760 |
72 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.14050648 |
73 | regulation of mast cell degranulation (GO:0043304) | 3.13403040 |
74 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.13343291 |
75 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.10541086 |
76 | * positive regulation of interleukin-12 production (GO:0032735) | 3.09676170 |
77 | pinocytosis (GO:0006907) | 3.08301076 |
78 | positive regulation of type 2 immune response (GO:0002830) | 3.07688455 |
79 | * cellular response to interferon-gamma (GO:0071346) | 3.07497696 |
80 | negative regulation of T cell mediated immunity (GO:0002710) | 3.06369672 |
81 | negative regulation of interleukin-12 production (GO:0032695) | 3.05591983 |
82 | detection of biotic stimulus (GO:0009595) | 3.04874465 |
83 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.03719772 |
84 | myeloid leukocyte activation (GO:0002274) | 3.02266233 |
85 | response to protozoan (GO:0001562) | 3.01795726 |
86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99556395 |
87 | positive regulation of mast cell activation (GO:0033005) | 2.99480573 |
88 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.99373894 |
89 | regulation of leukocyte degranulation (GO:0043300) | 2.98844152 |
90 | positive regulation of mast cell degranulation (GO:0043306) | 2.97707536 |
91 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.97707536 |
92 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.96079836 |
93 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.96079671 |
94 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.95311559 |
95 | superoxide anion generation (GO:0042554) | 2.94880925 |
96 | negative regulation of interleukin-17 production (GO:0032700) | 2.92855703 |
97 | dendritic cell differentiation (GO:0097028) | 2.91488738 |
98 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91298786 |
99 | T cell migration (GO:0072678) | 2.91031796 |
100 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.90952332 |
101 | leukocyte mediated cytotoxicity (GO:0001909) | 2.90205776 |
102 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.89720403 |
103 | regulation of mast cell activation (GO:0033003) | 2.88769485 |
104 | T-helper 1 type immune response (GO:0042088) | 2.87413550 |
105 | leukocyte aggregation (GO:0070486) | 2.87169183 |
106 | response to interferon-beta (GO:0035456) | 2.87038146 |
107 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.87015597 |
108 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.86983158 |
109 | lymphocyte mediated immunity (GO:0002449) | 2.86712610 |
110 | monocyte chemotaxis (GO:0002548) | 2.85400033 |
111 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.84012715 |
112 | negative regulation of cell killing (GO:0031342) | 2.84012715 |
113 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.83982874 |
114 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83186136 |
115 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.82211327 |
116 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.81986811 |
117 | positive regulation of B cell mediated immunity (GO:0002714) | 2.81986811 |
118 | * response to interferon-gamma (GO:0034341) | 2.81767933 |
119 | lymphocyte chemotaxis (GO:0048247) | 2.80768953 |
120 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80305379 |
121 | regulation of mononuclear cell migration (GO:0071675) | 2.79895018 |
122 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79879263 |
123 | positive regulation of interleukin-10 production (GO:0032733) | 2.79547848 |
124 | negative regulation of innate immune response (GO:0045824) | 2.79225284 |
125 | negative regulation of B cell proliferation (GO:0030889) | 2.79142122 |
126 | mature B cell differentiation (GO:0002335) | 2.78957783 |
127 | * regulation of interleukin-12 production (GO:0032655) | 2.78914028 |
128 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.77366689 |
129 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77335853 |
130 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.76420152 |
131 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75035117 |
132 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.72370090 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.01020248 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.93380570 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.46892191 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.72108674 |
5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.38585076 |
6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.13723052 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.82806805 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.79692626 |
9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.67297057 |
10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.48929974 |
11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.24926378 |
12 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.19116673 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.09078356 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.84656711 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.80713097 |
16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.69783164 |
17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.69293348 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.61461447 |
19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.58647553 |
20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.37818168 |
21 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.25843756 |
22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.13918268 |
23 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.10418775 |
24 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.01108229 |
25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.98481442 |
26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.97700626 |
27 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.92514628 |
28 | MYB_26560356_Chip-Seq_TH2_Human | 1.92206609 |
29 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.91497727 |
30 | MAF_26560356_Chip-Seq_TH1_Human | 1.87137681 |
31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87132661 |
32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82429180 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81119134 |
34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.75330072 |
35 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69355963 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68451688 |
37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66564396 |
38 | MYB_26560356_Chip-Seq_TH1_Human | 1.64162311 |
39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61190429 |
40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58223445 |
41 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57816087 |
42 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.57374451 |
43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56942416 |
44 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51314288 |
45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49003101 |
46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46462713 |
47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46300794 |
48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45131697 |
49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40913944 |
50 | MYC_22102868_ChIP-Seq_BL_Human | 1.35944968 |
51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35003724 |
52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32889331 |
53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31898476 |
54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28929087 |
55 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28561342 |
56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28419998 |
57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28357635 |
58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26114982 |
59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24460213 |
60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24282253 |
61 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23336830 |
62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22571490 |
63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20972819 |
64 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.19101031 |
65 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.15492232 |
66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14990731 |
67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13562076 |
68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13068501 |
69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12811670 |
70 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10576962 |
71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07800236 |
72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07263389 |
73 | MAF_26560356_Chip-Seq_TH2_Human | 1.05924126 |
74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05599688 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99762154 |
76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99353818 |
77 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96718909 |
78 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96475652 |
79 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96332000 |
80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96145820 |
81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94801303 |
82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91819738 |
83 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91034866 |
84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90264433 |
85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87468253 |
86 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87358488 |
87 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86906115 |
88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86000530 |
89 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85973423 |
90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84643475 |
91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83627025 |
92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82941957 |
93 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.82508353 |
94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81814109 |
95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79807337 |
96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78957385 |
97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77619004 |
98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.77280029 |
99 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74491121 |
100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.74443974 |
101 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74206121 |
102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73420842 |
103 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70938030 |
104 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.70038147 |
105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69599164 |
106 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.68026608 |
107 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.65541187 |
108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64624006 |
109 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.62994533 |
110 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.62807998 |
111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.62613097 |
112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60291466 |
113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.59190521 |
114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.58255281 |
115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.57117202 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.26077309 |
2 | MP0003303_peritoneal_inflammation | 3.70110976 |
3 | MP0003436_decreased_susceptibility_to | 3.60761130 |
4 | MP0005387_immune_system_phenotype | 3.31066107 |
5 | MP0001790_abnormal_immune_system | 3.31066107 |
6 | MP0006082_CNS_inflammation | 3.28780554 |
7 | MP0009785_altered_susceptibility_to | 3.27794269 |
8 | MP0002148_abnormal_hypersensitivity_rea | 3.25024731 |
9 | MP0005000_abnormal_immune_tolerance | 3.22119393 |
10 | MP0002419_abnormal_innate_immunity | 3.09462368 |
11 | MP0001800_abnormal_humoral_immune | 3.06511970 |
12 | MP0005671_abnormal_response_to | 3.05595209 |
13 | MP0000685_abnormal_immune_system | 3.04388578 |
14 | MP0002452_abnormal_antigen_presenting | 2.96426334 |
15 | MP0005058_abnormal_lysosome_morphology | 2.89714990 |
16 | MP0004510_myositis | 2.84643675 |
17 | * MP0005025_abnormal_response_to | 2.83327663 |
18 | * MP0002723_abnormal_immune_serum | 2.66645967 |
19 | * MP0001819_abnormal_immune_cell | 2.42772818 |
20 | * MP0002420_abnormal_adaptive_immunity | 2.40209718 |
21 | MP0005464_abnormal_platelet_physiology | 2.21017997 |
22 | MP0003724_increased_susceptibility_to | 2.12365963 |
23 | MP0003172_abnormal_lysosome_physiology | 2.03931151 |
24 | MP0001853_heart_inflammation | 2.02427282 |
25 | MP0003191_abnormal_cellular_cholesterol | 1.98319274 |
26 | MP0002405_respiratory_system_inflammati | 1.95713726 |
27 | MP0004947_skin_inflammation | 1.90738887 |
28 | MP0001533_abnormal_skeleton_physiology | 1.87871575 |
29 | MP0001845_abnormal_inflammatory_respons | 1.87567461 |
30 | MP0009840_abnormal_foam_cell | 1.86913357 |
31 | MP0000716_abnormal_immune_system | 1.82401176 |
32 | MP0002398_abnormal_bone_marrow | 1.74116780 |
33 | MP0005310_abnormal_salivary_gland | 1.70720727 |
34 | MP0010155_abnormal_intestine_physiology | 1.65400016 |
35 | * MP0008469_abnormal_protein_level | 1.61987967 |
36 | MP0003300_gastrointestinal_ulcer | 1.60987440 |
37 | MP0000689_abnormal_spleen_morphology | 1.60482269 |
38 | MP0009333_abnormal_splenocyte_physiolog | 1.54906214 |
39 | MP0009278_abnormal_bone_marrow | 1.50350599 |
40 | MP0009764_decreased_sensitivity_to | 1.50004942 |
41 | MP0002166_altered_tumor_susceptibility | 1.48428251 |
42 | MP0002429_abnormal_blood_cell | 1.46294377 |
43 | MP0003448_altered_tumor_morphology | 1.44737102 |
44 | MP0002139_abnormal_hepatobiliary_system | 1.44148911 |
45 | MP0002006_tumorigenesis | 1.41827486 |
46 | MP0003075_altered_response_to | 1.40163024 |
47 | MP0002722_abnormal_immune_system | 1.39772333 |
48 | MP0003806_abnormal_nucleotide_metabolis | 1.38548875 |
49 | MP0002138_abnormal_hepatobiliary_system | 1.37561591 |
50 | MP0000343_altered_response_to | 1.35747957 |
51 | MP0003183_abnormal_peptide_metabolism | 1.28600166 |
52 | MP0000569_abnormal_digit_pigmentation | 1.26386880 |
53 | MP0002254_reproductive_system_inflammat | 1.26343045 |
54 | MP0002998_abnormal_bone_remodeling | 1.19482070 |
55 | MP0001545_abnormal_hematopoietic_system | 1.19398847 |
56 | MP0005397_hematopoietic_system_phenotyp | 1.19398847 |
57 | MP0005174_abnormal_tail_pigmentation | 1.17960870 |
58 | MP0003690_abnormal_glial_cell | 1.16777231 |
59 | MP0001873_stomach_inflammation | 1.16067341 |
60 | MP0000604_amyloidosis | 1.15418716 |
61 | MP0005166_decreased_susceptibility_to | 1.07683870 |
62 | MP0002933_joint_inflammation | 1.07329740 |
63 | MP0000858_altered_metastatic_potential | 1.03671321 |
64 | MP0001851_eye_inflammation | 1.01796935 |
65 | MP0003763_abnormal_thymus_physiology | 0.99823160 |
66 | MP0002277_abnormal_respiratory_mucosa | 0.97351615 |
67 | MP0000465_gastrointestinal_hemorrhage | 0.93665077 |
68 | MP0008004_abnormal_stomach_pH | 0.92410387 |
69 | MP0009763_increased_sensitivity_to | 0.91767104 |
70 | MP0003828_pulmonary_edema | 0.90893509 |
71 | MP0003566_abnormal_cell_adhesion | 0.88030047 |
72 | MP0002396_abnormal_hematopoietic_system | 0.86766072 |
73 | MP0010307_abnormal_tumor_latency | 0.85231171 |
74 | MP0005390_skeleton_phenotype | 0.84706194 |
75 | MP0005076_abnormal_cell_differentiation | 0.83784855 |
76 | MP0004808_abnormal_hematopoietic_stem | 0.80345520 |
77 | MP0000249_abnormal_blood_vessel | 0.80225310 |
78 | MP0000371_diluted_coat_color | 0.79093985 |
79 | MP0003453_abnormal_keratinocyte_physiol | 0.78300170 |
80 | MP0000015_abnormal_ear_pigmentation | 0.74607330 |
81 | MP0002136_abnormal_kidney_physiology | 0.74496952 |
82 | MP0004782_abnormal_surfactant_physiolog | 0.74324795 |
83 | MP0005451_abnormal_body_composition | 0.73854209 |
84 | MP0000703_abnormal_thymus_morphology | 0.73007439 |
85 | MP0008874_decreased_physiological_sensi | 0.72380330 |
86 | MP0005164_abnormal_response_to | 0.70925059 |
87 | MP0005167_abnormal_blood-brain_barrier | 0.70669948 |
88 | MP0009765_abnormal_xenobiotic_induced | 0.69500096 |
89 | MP0003866_abnormal_defecation | 0.69454534 |
90 | MP0002132_abnormal_respiratory_system | 0.68800191 |
91 | MP0000490_abnormal_crypts_of | 0.66566409 |
92 | MP0003091_abnormal_cell_migration | 0.66272000 |
93 | MP0000767_abnormal_smooth_muscle | 0.62427426 |
94 | MP0002332_abnormal_exercise_endurance | 0.60951922 |
95 | MP0005165_increased_susceptibility_to | 0.60656698 |
96 | MP0008260_abnormal_autophagy | 0.59448127 |
97 | MP0003656_abnormal_erythrocyte_physiolo | 0.59176662 |
98 | MP0001663_abnormal_digestive_system | 0.58950693 |
99 | MP0003795_abnormal_bone_structure | 0.58830096 |
100 | MP0002693_abnormal_pancreas_physiology | 0.58045994 |
101 | MP0000609_abnormal_liver_physiology | 0.57447992 |
102 | MP0000920_abnormal_myelination | 0.57380206 |
103 | MP0002019_abnormal_tumor_incidence | 0.56738470 |
104 | MP0005257_abnormal_intraocular_pressure | 0.56139282 |
105 | MP0003186_abnormal_redox_activity | 0.55384375 |
106 | MP0010352_gastrointestinal_tract_polyps | 0.53562655 |
107 | MP0004883_abnormal_blood_vessel | 0.52641080 |
108 | MP0005319_abnormal_enzyme/_coenzyme | 0.51251944 |
109 | MP0008873_increased_physiological_sensi | 0.50660064 |
110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.49629624 |
111 | MP0005535_abnormal_body_temperature | 0.49506894 |
112 | MP0003045_fibrosis | 0.48787362 |
113 | MP0002090_abnormal_vision | 0.47857818 |
114 | MP0005023_abnormal_wound_healing | 0.47703490 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.94437679 |
2 | Recurrent bacterial skin infections (HP:0005406) | 6.36916136 |
3 | Eczematoid dermatitis (HP:0000976) | 6.11044884 |
4 | Systemic lupus erythematosus (HP:0002725) | 5.26998751 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.25971648 |
6 | Abnormality of macrophages (HP:0004311) | 4.56400517 |
7 | Mediastinal lymphadenopathy (HP:0100721) | 4.40567065 |
8 | Increased cerebral lipofuscin (HP:0011813) | 4.38885380 |
9 | Vacuolated lymphocytes (HP:0001922) | 4.26940422 |
10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.26545038 |
11 | Recurrent skin infections (HP:0001581) | 4.22593683 |
12 | Myositis (HP:0100614) | 4.16698767 |
13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.00053483 |
14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.92350200 |
15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.92350200 |
16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.92350200 |
17 | Obstructive lung disease (HP:0006536) | 3.91522379 |
18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.91522379 |
19 | Recurrent fungal infections (HP:0002841) | 3.85773160 |
20 | Orchitis (HP:0100796) | 3.83844329 |
21 | Glomerulonephritis (HP:0000099) | 3.83818786 |
22 | Vasculitis (HP:0002633) | 3.75550629 |
23 | Recurrent viral infections (HP:0004429) | 3.73821240 |
24 | Retrobulbar optic neuritis (HP:0100654) | 3.67636240 |
25 | Optic neuritis (HP:0100653) | 3.67636240 |
26 | Cellulitis (HP:0100658) | 3.63685748 |
27 | Colitis (HP:0002583) | 3.49278761 |
28 | Gingivitis (HP:0000230) | 3.48026287 |
29 | Chronic otitis media (HP:0000389) | 3.39718687 |
30 | Meningitis (HP:0001287) | 3.37957667 |
31 | Autoimmune thrombocytopenia (HP:0001973) | 3.34881728 |
32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.23880654 |
33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.23880654 |
34 | Agammaglobulinemia (HP:0004432) | 3.21563794 |
35 | Dysostosis multiplex (HP:0000943) | 3.17683306 |
36 | Stomatitis (HP:0010280) | 3.05991746 |
37 | Inflammation of the large intestine (HP:0002037) | 3.02523265 |
38 | Pustule (HP:0200039) | 3.01042232 |
39 | Disinhibition (HP:0000734) | 2.94897354 |
40 | Axonal loss (HP:0003447) | 2.91711413 |
41 | Loss of speech (HP:0002371) | 2.89642880 |
42 | Abnormality of complement system (HP:0005339) | 2.86898789 |
43 | Recurrent pneumonia (HP:0006532) | 2.86575530 |
44 | Basal ganglia calcification (HP:0002135) | 2.85163587 |
45 | Gastrointestinal stroma tumor (HP:0100723) | 2.82437118 |
46 | Interstitial pulmonary disease (HP:0006530) | 2.81231583 |
47 | Gastrointestinal inflammation (HP:0004386) | 2.80987035 |
48 | Osteomyelitis (HP:0002754) | 2.79813867 |
49 | Nephritis (HP:0000123) | 2.73385283 |
50 | Hematochezia (HP:0002573) | 2.72977810 |
51 | Periodontitis (HP:0000704) | 2.69940864 |
52 | Purpura (HP:0000979) | 2.69918587 |
53 | Myocardial infarction (HP:0001658) | 2.68177361 |
54 | Urticaria (HP:0001025) | 2.65996069 |
55 | Recurrent bronchitis (HP:0002837) | 2.63904103 |
56 | Recurrent lower respiratory tract infections (HP:0002783) | 2.60669721 |
57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.58489308 |
58 | Increased serum ferritin (HP:0003281) | 2.53029916 |
59 | Arterial thrombosis (HP:0004420) | 2.52988650 |
60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.52547719 |
61 | Mutism (HP:0002300) | 2.52481399 |
62 | Complement deficiency (HP:0004431) | 2.51182098 |
63 | Prostate neoplasm (HP:0100787) | 2.49714094 |
64 | Emphysema (HP:0002097) | 2.46911444 |
65 | Mucopolysacchariduria (HP:0008155) | 2.46574210 |
66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46574210 |
67 | Thick nail (HP:0001805) | 2.45214831 |
68 | IgM deficiency (HP:0002850) | 2.44253912 |
69 | Spontaneous hematomas (HP:0007420) | 2.43737289 |
70 | Leukocytosis (HP:0001974) | 2.40828245 |
71 | Chest pain (HP:0100749) | 2.40706172 |
72 | Nasal polyposis (HP:0100582) | 2.40441178 |
73 | Increased IgM level (HP:0003496) | 2.39815376 |
74 | * Pulmonary infiltrates (HP:0002113) | 2.39228231 |
75 | Hepatosplenomegaly (HP:0001433) | 2.37483347 |
76 | Hemoptysis (HP:0002105) | 2.35877921 |
77 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.35497520 |
78 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.35497520 |
79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.35497520 |
80 | Gastrointestinal infarctions (HP:0005244) | 2.31065072 |
81 | Agnosia (HP:0010524) | 2.28289502 |
82 | Autoimmune hemolytic anemia (HP:0001890) | 2.27800347 |
83 | Keratoconjunctivitis sicca (HP:0001097) | 2.26644614 |
84 | Gangrene (HP:0100758) | 2.24801101 |
85 | Epistaxis (HP:0000421) | 2.24460159 |
86 | T lymphocytopenia (HP:0005403) | 2.24292390 |
87 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23379430 |
88 | Abnormality of the pleura (HP:0002103) | 2.22527504 |
89 | Hypergammaglobulinemia (HP:0010702) | 2.22117699 |
90 | Panhypogammaglobulinemia (HP:0003139) | 2.21445656 |
91 | IgA deficiency (HP:0002720) | 2.20487673 |
92 | Abnormality of T cells (HP:0002843) | 2.20416139 |
93 | Prolonged bleeding time (HP:0003010) | 2.20174875 |
94 | Increased IgE level (HP:0003212) | 2.19579726 |
95 | Gingival bleeding (HP:0000225) | 2.18711941 |
96 | Abnormality of T cell number (HP:0011839) | 2.18455858 |
97 | Polyneuropathy (HP:0001271) | 2.17068116 |
98 | Keratoconjunctivitis (HP:0001096) | 2.15692377 |
99 | Abnormality of the nasal mucosa (HP:0000433) | 2.15301871 |
100 | Abnormality of iron homeostasis (HP:0011031) | 2.13696968 |
101 | Lymphopenia (HP:0001888) | 2.13029062 |
102 | Amyloidosis (HP:0011034) | 2.12783269 |
103 | Recurrent sinusitis (HP:0011108) | 2.12305055 |
104 | Petechiae (HP:0000967) | 2.11764287 |
105 | Abnormality of the prostate (HP:0008775) | 2.11390339 |
106 | Pulmonary embolism (HP:0002204) | 2.10936374 |
107 | Sepsis (HP:0100806) | 2.09439918 |
108 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09323755 |
109 | Restrictive lung disease (HP:0002091) | 2.09316084 |
110 | Neuronal loss in central nervous system (HP:0002529) | 2.08500307 |
111 | Premature loss of primary teeth (HP:0006323) | 2.06454227 |
112 | Granulocytopenia (HP:0001913) | 2.05432485 |
113 | Abnormality of B cell number (HP:0010975) | 2.04090985 |
114 | Chronic sinusitis (HP:0011109) | 2.04061472 |
115 | Progressive neurologic deterioration (HP:0002344) | 2.03730741 |
116 | Encephalitis (HP:0002383) | 2.02113660 |
117 | Eosinophilia (HP:0001880) | 2.01885266 |
118 | Joint hemorrhage (HP:0005261) | 1.99428314 |
119 | * Skin ulcer (HP:0200042) | 1.94888762 |
120 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.93896331 |
121 | Osteolytic defects of the hand bones (HP:0009699) | 1.93896331 |
122 | Chronic diarrhea (HP:0002028) | 1.93838962 |
123 | Abnormality of T cell physiology (HP:0011840) | 1.92723794 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.07786425 |
2 | MAP3K14 | 3.97568689 |
3 | RIPK4 | 3.85496280 |
4 | BLK | 3.66170394 |
5 | TYK2 | 3.47891295 |
6 | IRAK3 | 3.26371948 |
7 | IRAK4 | 3.05404201 |
8 | PRPF4B | 2.92888951 |
9 | * TBK1 | 2.74562552 |
10 | IKBKE | 2.51192656 |
11 | KIT | 2.50899499 |
12 | CSF1R | 2.50092155 |
13 | ERN1 | 2.42834310 |
14 | * IKBKB | 2.25929973 |
15 | TGFBR2 | 2.24076095 |
16 | JAK3 | 2.13584874 |
17 | JAK1 | 2.05068584 |
18 | MAP3K13 | 2.02231398 |
19 | SYK | 1.84478757 |
20 | CSK | 1.64656381 |
21 | BTK | 1.58343147 |
22 | EPHB1 | 1.52819731 |
23 | TXK | 1.51420371 |
24 | ZAP70 | 1.49612522 |
25 | PIM2 | 1.47503922 |
26 | PBK | 1.46830295 |
27 | STK10 | 1.46469668 |
28 | TNK2 | 1.45409359 |
29 | CHUK | 1.44987407 |
30 | HCK | 1.44868884 |
31 | TAOK1 | 1.43973647 |
32 | FES | 1.42717969 |
33 | LYN | 1.38997721 |
34 | TESK2 | 1.37123326 |
35 | MAP2K3 | 1.27500606 |
36 | NEK9 | 1.26017492 |
37 | TAOK3 | 1.23236346 |
38 | RPS6KA4 | 1.22072439 |
39 | LCK | 1.21250467 |
40 | FGR | 1.16950030 |
41 | TEC | 1.12224599 |
42 | CDC42BPA | 1.10113542 |
43 | PIM1 | 1.08136045 |
44 | MATK | 1.07365763 |
45 | MARK3 | 1.05440203 |
46 | JAK2 | 1.05294517 |
47 | NME2 | 0.99866095 |
48 | GRK7 | 0.99161196 |
49 | SMG1 | 0.98476411 |
50 | DDR2 | 0.97356166 |
51 | CLK1 | 0.96554801 |
52 | BMPR2 | 0.94011528 |
53 | MAP3K10 | 0.93819418 |
54 | MAP3K11 | 0.86124681 |
55 | GRK6 | 0.82341547 |
56 | MST4 | 0.82295431 |
57 | FGFR4 | 0.81778197 |
58 | SIK2 | 0.81270167 |
59 | LRRK2 | 0.80648129 |
60 | IRAK2 | 0.78087817 |
61 | ITK | 0.74302581 |
62 | FGFR3 | 0.68928120 |
63 | MAP3K5 | 0.67148176 |
64 | STK4 | 0.65581989 |
65 | ABL1 | 0.64611015 |
66 | EGFR | 0.63775765 |
67 | PRKCD | 0.63647967 |
68 | EIF2AK2 | 0.63588740 |
69 | BMX | 0.63254679 |
70 | MAP3K3 | 0.61997863 |
71 | SIK3 | 0.60194959 |
72 | MAPK7 | 0.58314873 |
73 | PRKD2 | 0.57710933 |
74 | PTK6 | 0.57063157 |
75 | ABL2 | 0.56448095 |
76 | PRKCQ | 0.55625000 |
77 | PDPK1 | 0.55440753 |
78 | MAP2K6 | 0.54524805 |
79 | CAMK1D | 0.54457455 |
80 | CDK4 | 0.54086143 |
81 | IRAK1 | 0.53749890 |
82 | HIPK2 | 0.52952073 |
83 | MOS | 0.52519368 |
84 | TRPM7 | 0.50221251 |
85 | MAPKAPK2 | 0.48932535 |
86 | EPHA3 | 0.47496077 |
87 | YES1 | 0.47164096 |
88 | ARAF | 0.46810247 |
89 | MARK2 | 0.43009255 |
90 | MAPK11 | 0.42357975 |
91 | PAK4 | 0.41838933 |
92 | PIK3CG | 0.41656464 |
93 | RPS6KA6 | 0.41655949 |
94 | FLT3 | 0.39758143 |
95 | SIK1 | 0.39613310 |
96 | NUAK1 | 0.39003984 |
97 | PDK1 | 0.38791707 |
98 | BCKDK | 0.38655464 |
99 | DAPK2 | 0.37257989 |
100 | PKN1 | 0.36868080 |
101 | STK24 | 0.36598109 |
102 | NLK | 0.36378427 |
103 | TAOK2 | 0.35034835 |
104 | SCYL2 | 0.34805931 |
105 | TTN | 0.32142662 |
106 | CAMKK2 | 0.31618170 |
107 | FYN | 0.30849836 |
108 | MAP3K8 | 0.30759230 |
109 | CDK6 | 0.30598845 |
110 | KDR | 0.29641543 |
111 | MAPK4 | 0.29492749 |
112 | RPS6KA2 | 0.28463900 |
113 | DYRK1B | 0.27649504 |
114 | RIPK1 | 0.27108033 |
115 | STK3 | 0.26775754 |
116 | ADRBK2 | 0.26666152 |
117 | RPS6KA5 | 0.26388089 |
118 | ACVR1B | 0.26299949 |
119 | TRIB3 | 0.26214880 |
120 | IGF1R | 0.25640025 |
121 | RPS6KC1 | 0.25104879 |
122 | RPS6KL1 | 0.25104879 |
123 | MAPK12 | 0.25036661 |
124 | MAP3K1 | 0.24806704 |
125 | INSR | 0.23906246 |
126 | KSR2 | 0.22613115 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.51857922 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.41613857 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.75748315 |
4 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.73552068 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.73429220 |
6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.66116753 |
7 | Pertussis_Homo sapiens_hsa05133 | 2.40179536 |
8 | Legionellosis_Homo sapiens_hsa05134 | 2.26337740 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 2.21311293 |
10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.19394906 |
11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17559450 |
12 | Lysosome_Homo sapiens_hsa04142 | 2.16765039 |
13 | Allograft rejection_Homo sapiens_hsa05330 | 2.15816587 |
14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.14198368 |
15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.11678574 |
16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.10897370 |
17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.10243411 |
18 | Measles_Homo sapiens_hsa05162 | 2.07401431 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05788346 |
20 | Malaria_Homo sapiens_hsa05144 | 2.04461064 |
21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02348376 |
22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.98079296 |
23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93743920 |
24 | Influenza A_Homo sapiens_hsa05164 | 1.80315809 |
25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.71340093 |
26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70379204 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69892196 |
28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65886498 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65535710 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60874144 |
31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57133791 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.51707308 |
33 | Salmonella infection_Homo sapiens_hsa05132 | 1.50220984 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48409696 |
35 | Asthma_Homo sapiens_hsa05310 | 1.48132713 |
36 | Apoptosis_Homo sapiens_hsa04210 | 1.47801450 |
37 | Phagosome_Homo sapiens_hsa04145 | 1.42230451 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.37595482 |
39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36052860 |
40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33984224 |
41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.30534334 |
42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22828043 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.12958730 |
44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12249253 |
45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09235627 |
46 | Hepatitis C_Homo sapiens_hsa05160 | 1.06404717 |
47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05114583 |
48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02215699 |
49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01030193 |
50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00935847 |
51 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00303642 |
52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98430206 |
53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98143182 |
54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89699833 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88195798 |
56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86481688 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77806568 |
58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77430876 |
59 | Platelet activation_Homo sapiens_hsa04611 | 0.72294693 |
60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71879231 |
61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71752069 |
62 | Amoebiasis_Homo sapiens_hsa05146 | 0.69865508 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66521446 |
64 | Prion diseases_Homo sapiens_hsa05020 | 0.65387581 |
65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64159918 |
66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57955428 |
67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56409237 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51193418 |
69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51060589 |
70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47181735 |
71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47009759 |
72 | Bladder cancer_Homo sapiens_hsa05219 | 0.46190559 |
73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44720677 |
74 | Endocytosis_Homo sapiens_hsa04144 | 0.38531874 |
75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37182260 |
76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35931693 |
77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34637785 |
78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34485328 |
79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33863322 |
80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32962033 |
81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30663733 |
82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29535608 |
83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29475610 |
84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29348447 |
85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29235593 |
86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29016466 |
87 | ABC transporters_Homo sapiens_hsa02010 | 0.24486720 |
88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24184213 |
89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23012960 |
90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20645146 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.20020632 |
92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18880559 |
93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.17530080 |
94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.17513109 |
95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17446240 |
96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17283802 |
97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.16874525 |
98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15884746 |
99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14923388 |
100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.14882914 |
101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.14655192 |
102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13682088 |
103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.13389574 |
104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13086563 |
105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.10660075 |
106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.10516437 |
107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10023653 |
108 | Mineral absorption_Homo sapiens_hsa04978 | 0.09772170 |
109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.09710584 |
110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.07713928 |
111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.04511744 |